PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
June 1, 2024Journal of Clinical Oncology

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: Propensity score–matched recurrence-free, distant metastasis-free, and overall survival analysis.

View Full Paper
Ask AI
Bookmark
Share

Authors

MBManja BloemMMMelissa M. de MezaMAMaureen J.B. Aarts

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bloem et al. (2024) studied this question.

synapsesocial.com/papers/68e66eeab6db6435875f93d8https://doi.org/10.1200/jco.2024.42.16_suppl.9573
View Full Paper
Ask AI
Bookmark
Share